Molecular profile
- Sequence
- Ac-Nle-Asp(1)-His-D-Phe-Arg-Trp-Lys(1)
- Molecular Formula
- C 50 H 68 N 14 O 10
- Molecular Weight
- 1025.182 g/mol
- PubChem CID
- 9941379
- CAS Number
- 189691-06-3
Peptide research profile
PT-141
Also known as Bremelanotide
PT-141, also known by its generic clinical name Bremelanotide, is a synthetic peptide derived from alpha-melanocyte-stimulating hormone (α-MSH). It has undergone clinical trials as a potential treatment for hypoactive sexual desire disorder (HSDD) in both men and women, as well as for acute hemorrhage. It acts as an agonist for the melanocortin-4 receptor (MC4R) and the melanocortin-1 receptor (MC1R).…
Dosing literacy
Dosing & scaling, explained
The moderated mass amounts below are retained for comparison. Near-duplicates, mix-dependent volumes and device markings are excluded. This is educational source context—not a protocol or recommendation.
Recorded amount context
Mass amounts available for comparison
- Lower range1 mgTypical Dose
Recorded example with no verified study backing; shown for amount literacy only.
- Mid range4 mgTypical Dose
Recorded example with no verified study backing; shown for amount literacy only.
Only mcg or mg amounts are retained. The calculator derives mL, syringe units or pen clicks from the current vial strength, water volume and device.
Schedule literacy
No independently verified schedule
Evidence context
No clinical amount or schedule is inferred from this material. Source verification is pending, and every displayed amount remains educational context rather than guidance.
Research best practices
Storage, handling and interpretation
Product identity
Verify the exact compound, formulation and amount against the product label or certificate before calculation.
Storage & handling
Follow the product label, certificate and validated laboratory SOP; no universal storage assumption is applied here.
Prepared solutions
Label concentration and preparation date, use sterile technique where applicable, and follow a validated stability protocol.
Research orientation
What researchers are exploring
These themes organize the educational information currently available. Individual claims remain under source review and are not treatment claims.
- 01
Research on PT-141
Scientific findings and therapeutic applications
Evidence map
What is known—and what still needs verification
Available context is organized without assigning unsupported study models or evidence grades.
- Source review pending
Research on PT-141
Scientific findings and therapeutic applications
Recorded protocol library
Amounts recorded for PT-141
These amount records are independent from vial strength, reconstitution volume and measuring device. A recorded source is not the same as study backing, and these values are not recommendations.
- 01
Typical Dose
1 mg
Sign in for schedule, duration and source context.
- 02
Typical Dose
4 mg
Sign in for schedule, duration and source context.
Technical reference
Identity, limitations and unknowns
Important limitations
- Individual claims and source links have not yet completed editorial verification.
- Evidence level, applicable study model, formulation, route and population remain unassigned.
Source review
1 links awaiting verification
- Source link · pmc.ncbi.nlm.nih.govVerification pending · Source review pending